Rampart
THE PRODUCT
Rampart Dual Layer Matrix is a dehydrated amniotic membrane sheet, protective covering, and barrier to aid in wound therapy.
BENEFITS OF RAMP ART
Dual-layer
Composed of two layers of amniotic tissue
Versatile orientation
Non-side specific orientation for application eliminates restrictions in surgical repair
Chorion-free
Immune privileged approach reduces the risk of adverse events
Thick membrane
Ideal for deep wounds and exposed anatomy, offering effortless positioning and repositioning for optimal conformity
Advanced tensile strength
Allows for strong adherence and easy application
Preserved proteins
Preserves essential structural proteins and ECM biochemicals naturally inherent to placental tissue
Backpacking Trips
Fuerat aestu carentem habentia spectent tonitrua mutastis locavit liberioris inistra possedit.
OUR PURAMP PROCESS
OUR PURAMP PROCESS
SAFETY + VERSATILITY
- Amniotic tissue is recovered f rom healthy mothers who have undergone full-term delivery
- Rampart is processed in accordance with FDA regulations and AATB standards
- The amniotic membrane has distinct non-immunological attributes
- Requires no up-f ront preparation
- Ambient temperature storage
- Can be applied on either side of the sheet
- E-Beam sterilization provides a sterility assurance level (SAL) of 10-6
PRODUCT DETAILS
Rampart’s protective amnion properties create an ideal barrier to protect soft tissue from the surrounding environment. Processed with minimal manipulation, it retains the qualities of the native extracellular matrix (ECM). Rampart can be applied in any orientation, quickly hydrates in situ, and naturally stays in place, eliminating application placement limitations.
The product is a barrier to protect:
- Diabetic ulcers
- Venous ulcers
- Pressure ulcers
- Burns
- Wounds with exposed tendons, muscles, or bones
Proteins in the product include:
- Collagen I, III, IV, V, and VII
- Elastina
- Fibronectin
- Laminin
OUR PŪRAMP PROCESS
Tissue collection
Placental tissue is donated from live births in the U.S. without harming the mother or baby
Donor screening
A thorough medical and social history is obtained for each donor to ensure eligibility requirements are met
Infectious disease testing
• HBsAg •HBcAb • HCVAb • HCV NAT • HBV NAT • HIV NAT • HIV 1/2Ab • WNV NAT • HTLV I/II Ab • RPR/STS
Tissue processing
All tissue undergoes a proprietary cleansing process to remove blood contaminants and reduce bioburden
Tissue sterilization
Tissue is sterilized for an additional level of safety, achieving a sterility assurance level (SAL) of 10-6